Legal Opinion

Freeman v. Hoffman-La Roche, Inc.

Nebraska Supreme Court

Decided October 27, 2000No. S-98-1095PublishedCited by 68 opinions

1Opinion of the CourtConnolly, J.

In this appeal, we reconsider our approach to products liability for defects in prescription drugs in light of changes in the law and the release of Restatement (Third) of Torts: Products Liability §§ 1 to 21 (1997) (Third Restatement). The appellant, Aimee Freeman, filed a petition alleging seven theories of recovery against the appellee pharmaceutical company, Hoffman-La Roche, Inc. (Hoffman). She seeks damages for injuries she sustained following her use of the prescription drug Accutane. Hoffman demurred on the basis that the petition failed to state a cause of action. Based on our…

2Cases cited35 opinions

  1. Feldman v. Lederle LaboratoriesSupreme Court of New Jersey · 1984
  2. Brown v. Superior CourtCalifornia Supreme Court · 1988
  3. Collins v. Eli Lilly & Co.Wisconsin Supreme Court · 1984
  4. Perez v. Wyeth Laboratories Inc.Supreme Court of New Jersey · 1999
  5. Rahmig v. Mosley MacHinery Co.Nebraska Supreme Court · 1987

30 more not listed; retrieve them via the Exa API.

3Cited by68 opinions

  1. Gourdine v. CrewsCourt of Appeals of Maryland · 2008
  2. Lance v. WyethSupreme Court of Pennsylvania · 2014
  3. Shuck v. CNH AMERICA, LLCCourt of Appeals for the Eighth Circuit · 2007
  4. Amanda Watts v. Medicis Pharmaceutical CorporationArizona Supreme Court · 2016
  5. In re Baycol Products LitigationDistrict Court, D. Minnesota · 2003

63 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API